This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2015-2019.
Location History:
- Osaka, JP (2015)
- Kitajima-cho, JP (2018 - 2019)
Company Filing History:
Years Active: 2015-2019
Title: Innovations of Yukitaka Uematsu in Tuberculosis Treatment
Introduction
Yukitaka Uematsu is a notable inventor based in Kitajima-cho, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating tuberculosis. With a total of three patents to his name, Uematsu's work is recognized for its potential impact on public health.
Latest Patents
Uematsu's latest patents focus on heterobicyclic compounds and their use for the treatment of tuberculosis. The primary objective of these inventions is to provide compounds that exhibit excellent antibacterial activity against tuberculosis bacteria, multidrug-resistant tuberculosis bacteria, and non-tuberculous mycobacteria. The compounds are described by a general formula, with specific symbols defined in the attached specifications, or as salts thereof.
Career Highlights
Yukitaka Uematsu is currently associated with Otsuka Pharmaceutical Company, Limited, where he continues to innovate in the pharmaceutical sector. His work is crucial in addressing the challenges posed by drug-resistant strains of tuberculosis, which remain a significant global health issue.
Collaborations
Uematsu has collaborated with notable colleagues such as Hiroshi Shimizu and Yoshikazu Kawano. These partnerships have likely contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Yukitaka Uematsu's contributions to the field of tuberculosis treatment through his innovative patents highlight the importance of ongoing research in combating infectious diseases. His work at Otsuka Pharmaceutical Company, Limited, along with his collaborations, underscores the collaborative effort needed to tackle public health challenges effectively.